Research
Research Focus
Research in the Bhide Lab focuses on early brain development and the neurobiological mechanisms that produce developmental diabilities. The goal is to better understand these mechanisms and to develop novel tools for diagnosis and treatment of these disabilities.
Neurotransmitters are known for there actions as chemical messangers in the mature brain, however in the developing brain they act as growth promoting substances. They influence prosesses such as:
- Neurogenesis, the production of neurons
- Neuronal migratoin, or how neurons find their way to final destinations
Research focuses on how neurotransmitter imbalance in the developing brain occuring as a result of drugs prescription or otherwise, and how it affects brain development, development of behavior, and how it impacts the individual when they become an adult.
Other research in the Lab focuses on childhood onset movement disorders. With the gracious support of a local Tallahassee family, Dr. Bhide and his team have established the Brian Jackson Dystonia Research and Discovery Program that uses molecular, genetic, as well as developmental neurobiological research aimed at better understanding the disease. The program seeks to understand how Dystonia develops, progress in early diagnosis, and development of novel treatment mechanisms.
Discoveries in the Lab
In research to understand how imbalances in neurotransmitters affects cognitive performance, the team has looked at attention, executive function, cognitive flexability, etc. to help identify neurobiological mechanisms and led to the discovery of a novel drug for the treatment of ADHD. Dr. Bhide has worked to create a startup comany in Tallahasse that is developing the drug discovered in the lab to potentially treat ADHD across the world.